Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoma, Non-Hodgkin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05409066
What this trial is testing

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma

Who this might be right for
Follicular Lymphoma (FL)
Genmab 549
Testing effectiveness (Phase 2)Study completedNCT00506129
What this trial is testing

Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma

Who this might be right for
LymphomaDisorder Related to Bone Marrow Transplantation
M.D. Anderson Cancer Center 33
Early research (Phase 1)Study completedNCT02568553
What this trial is testing

Lenalidomide and Blinatumomab for the Treatment of Relapsed Non-Hodgkin Lymphoma

Who this might be right for
Recurrent Burkitt LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent Grade 1 Follicular Lymphoma+23 more
National Cancer Institute (NCI) 35
Early research (Phase 1)Ended earlyNCT03121677
What this trial is testing

Personalized Tumor Vaccine Strategy and PD-1 Blockade in Patients With Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Washington University School of Medicine 4
Testing effectiveness (Phase 2)Ended earlyNCT02420795
What this trial is testing

Akt/ERK Inhibitor ONC201 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Central Nervous System LymphomaGastric Mantle Cell LymphomaRecurrent Mantle Cell Lymphoma+4 more
M.D. Anderson Cancer Center 16
Not applicableUnknownNCT04048395
What this trial is testing

Clinical Outcomes of Early-progressed Follicular Lymphoma in Korea

Who this might be right for
Follicular Lymphoma
Samsung Medical Center 80
Not applicableUnknownNCT02039895
What this trial is testing

Helical Irradiation of Total Skin (HITS) for Cutaneous Lymphoma

Who this might be right for
Cutaneous T-cell Lymphoma
Far Eastern Memorial Hospital 10
Early research (Phase 1)Study completedNCT01791595
What this trial is testing

A Phase I Trial of AZD3965 in Patients With Advanced Cancer

Who this might be right for
Adult Solid TumorDiffuse Large B Cell LymphomaBurkitt Lymphoma
Cancer Research UK 53
Testing effectiveness (Phase 2)Study completedNCT03192202
What this trial is testing

AFM13 in Relapsed/Refractory Cutaneous Lymphomas

Who this might be right for
Lymphoma, T-Cell, Cutaneous
Ahmed Sawas 18
Early research (Phase 1)UnknownNCT04004637
What this trial is testing

CD7 CAR-T Cells for Patients With R/R CD7+ NK/T Cell Lymphoma,T-lymphoblastic Lymphoma and Acute Lymphocytic Leukemia

Who this might be right for
T-lymphoblastic LymphomaNK/T Cell LymphomaAcute Lymphocytic Leukemia
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Early research (Phase 1)Ended earlyNCT00369629
What this trial is testing

Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome

Who this might be right for
Lymphoma
Northwestern University 14
Not applicableStudy completedNCT06032806
What this trial is testing

Effects of 8 Weeks Moderate and High Intensity Training on Hemoglobin Levels of Female Students

Who this might be right for
Moderate and High Intensity Training and Hemoglobin Levels
Riphah International University 28
Not applicableStudy completedNCT01815788
What this trial is testing

Evaluation of Efficacy and Patient Acceptance of Sound Amplifier Téo First, in Mild and Moderate Presbycusis Patient 60 Years of Age and Older, With no Previous Hearing Aid

Who this might be right for
Mild and Moderate Presbycusis
Centre Hospitalier Universitaire de Nice 31
Early research (Phase 1)Active Not RecruitingNCT05784441
What this trial is testing

JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)

Who this might be right for
Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
Janssen Research & Development, LLC 21
Testing effectiveness (Phase 2)Study completedNCT00251394
What this trial is testing

Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Dana-Farber Cancer Institute 30
Post-approval studies (Phase 4)UnknownNCT03150602
What this trial is testing

A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy

Who this might be right for
Peripheral T Cell LymphomaProgression, Disease
Taiwan Mundipharma Pharmaceuticals Ltd. 22
Not applicableWithdrawnNCT02141841
What this trial is testing

Effect of Age on the Median Effective Concentration(EC50) for Motor Block With Spinal Plain Bupivacaine

Who this might be right for
Mononeuropathy of the Median Nerve, Mild
China Three Gorges University, Yichang, China
Testing effectiveness (Phase 2)Study completedNCT00596154
What this trial is testing

Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-dose Chemotherapy With Autologous Stem-cell Rescue in Newly-diagnosed Primary CNS Lymphoma

Who this might be right for
CNS LymphomaCNS Brain CancerNon-Hodgkin's Lymphoma
Memorial Sloan Kettering Cancer Center 33
Testing effectiveness (Phase 2)Study completedNCT05844956
What this trial is testing

DZD8586 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (TAI-SHAN1)

Who this might be right for
Lymphoma, Non-Hodgkin
Dizal Pharmaceuticals 17
Testing effectiveness (Phase 2)Study completedNCT03364231
What this trial is testing

Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's Lymphoma

Who this might be right for
Marginal Zone LymphomaWaldenstrom MacroglobulinemiaNon Follicular Indolent Non-Hodgkin Lymphoma
TG Therapeutics, Inc. 21
Next Page